ArticleBMC complementary medicine and therapies2025
Rosmarinus Officinalis L. essential oil: in Silico molecular docking and in vivo nematocidal activity on intestinal and muscular trichinellosis.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.PLoS neglected tropical diseases · 2026Article
- Antiparasitic activity of peppermint and lavender essential oil nano-emulsions against Toxoplasma gondii RH strain in vitro and in vivo.Veterinary research communications · 2026Article
- Evaluation of prophylactic and therapeutic activity of camel whey protein and its trypsinized hydrolysate against experimental trichinellosis.BMC complementary medicine and therapies · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite its deleterious effects, modest activity in muscular larval stages and burgeoning resistance, the control of trichinellosis relies primarily on albendazole. To avert the shortfalls, Rosmarinus officinalis essential oil (ROEO), a promising traditional African phytotherapeutic agent, has been harnessed to evaluate its therapeutic profile on murine trichinellosis.
methodsEmploying in silico molecular docking, the interaction between phytochemicals of ROEO and possible targets, tubulin tyrosine ligase and thymidylate synthase was explored. The in vivo anti-Trichinella activity of a five-day oral treatment of 400 mg/kg/dose of ROEO was assessed against adult and larval stages via parasitological, ultrastructural, biochemical and histopathological studies.
resultsMolecular docking analysis revealed that the main constituents of ROEO exhibited variable interactions with both targets. Parasitologically, ROEO administration recorded a statistically significant reduction (84.0%R and 73.5%R) in mean worms recovered during the intestinal and muscular phases, respectively. Severe topographic deformities were observed in ROEO-treated worms. Biochemically, the highest antioxidant reduced glutathione level that constrained the detrimental oxidant malondialdehyde in serum was achieved by ROEO. Histopathologically, ROEO had obviously ameliorated inflammatory and fibrotic responses during the muscular stage.
conclusionsThis study is the first to highlight the in silico molecular docking and in vivo anti-Trichinella activity of ROEO. Its potentiality in inducing multistage activity and mitigating the inflammation in both intestine and muscles was greatly indebted to suppressing targeted proteins and its high antioxidant activity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.